OX2R
MOLECULAR TARGETOrexin receptor type 2
OX2R (Orexin receptor type 2) is targeted by 30 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting OX2R
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
About OX2R as a Drug Target
OX2R (Orexin receptor type 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 30 compounds with documented OX2R interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
OX2R inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.